Delivery Order SPE2DX22D0049-SPE2D826FA3PN
- Not listed
- AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $32,830.14 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract has an ultimate completion date of January 13, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued...
- AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $760,963.64 by the Defense Logistics Agency's Medical Supply Chain. The contract, awarded on January 13, 2026, carries a firm fixed-price structure with an ultimate completion date of January 14, 2026. This delivery order represents a child contract under AmerSourceBergen's parent organization, Cencora, Inc., and was competitively awarded with no...
- AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $15,657 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-set-aside award represents a competitive contract vehicle for pharmaceutical and medical supply procurement. The delivery order is issued under AmerSourceBergen's parent company Cencora, Inc.'s...
- AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $183,526.20 by the Defense Logistics Agency's Medical Supply Chain on January 9, 2026, with completion targeted for January 12, 2026. This non-competitive delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a single-award vehicle valued at up to $999,999,999.00 running through December 2026. The delivery order...
- AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $3,035.73 firm fixed-price delivery order (4570468002) by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. The award was made on a non-set-aside, competitive basis to the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with...
- AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $77,158.62 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. The award was made without a set-aside designation, indicating full and open competition. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under...
- AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,955.04 by the Defense Logistics Agency's Medical Supply Chain on September 13, 2025, with a completion date of September 15, 2025. This firm fixed price contract, which was not set-aside, represents a child order under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The...
- AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., received a $55,614 delivery order contract award on January 7, 2026, from the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract for pharmaceutical and medical supply delivery to be performed in Conshohocken, Pennsylvania. The delivery order represents a child contract under Cencora's larger Indefinite Delivery Contract with DLA Troop...
- AmerSourceBergen Drug Corp was awarded a delivery order valued at $115,054.02 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerSourceBergen's larger Indefinite Delivery Contract...
- AmerSourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,020.95 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain on September 30, 2025. This non-competitive delivery order represents a child contract under the company's broader pharmaceutical supply relationship with the federal government. The contract specifies performance at AmerSourceBergen's Conshohocken...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA3PNDelivery Order
AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $163,521.80 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. The contract is a firm fixed-price, non-set-aside award with performance taking place at the company's Conshohocken, Pennsylvania location. This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerSourceBergen's contract portfolio with the Defense Logistics Agency reflects the company's critical role as a pharmaceutical distributor for federal military and veteran healthcare systems. The underlying IDC encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains including diabetes management, neurology, pain management, and antibiotics. The company's consistent success in winning competitively awarded federal contracts demonstrates its capability to meet stringent government procurement requirements for essential medical commodities serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $163.5k | 1/11/26 |